Search filters

List of works by Ilaria Zanellato

A new platinum-based prodrug candidate: Its anticancer effects in B50 neuroblastoma rat cells

scientific article published on 23 August 2018

An unsymmetric cisplatin-based Pt(iv) derivative containing 2-(2-propynyl)octanoate: a very efficient multi-action antitumor prodrug candidate

scientific article published on 6 October 2017

Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen †

scientific article published on 24 June 2019

Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells

scientific article published on 13 September 2013

Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs

scientific article published on 23 February 2016

Antiproliferative effect of ferrocifen drug candidates on malignant pleural mesothelioma cell lines

Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: how long the organic chain should be?

scientific article published on 7 August 2014

Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs

scientific article published on 27 May 2015

Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what?

scientific article published on 16 January 2017

Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates

scientific article

Evaluation of Platinum-Ethacrynic Acid Conjugates in the Treatment of Mesothelioma

scientific article published on 24 October 2011

Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs

scientific article published on 6 August 2015

Functionalized nonporous silica nanoparticles as carriers for Pt(iv) anticancer prodrugs.

scientific article published on November 2016

Host–guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins

Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug

article published in 2018

In vitro anti-mesothelioma activity of cisplatin-gemcitabine combinations: evidence for sequence-dependent effects

scientific article published on 6 April 2010

JQ1, a BET inhibitor, synergizes with cisplatin and induces apoptosis in highly chemoresistant malignant pleural mesothelioma cells

scientific article published on 23 June 2017

May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs?

scientific article published on 17 November 2016

Metallo-drugs in the treatment of malignant pleural mesothelioma

One-Pot Multienzymatic Synthesis of 12-Ketoursodeoxycholic Acid: Subtle Cofactor Specificities Rule the Reaction Equilibria of Five Biocatalysts Working in a Row

Platinum-bisphosphonate complexes have proven to be inactive chemotherapeutics targeted for malignant mesothelioma because of inappropriate hydrolysis

scientific article published on 30 December 2010

Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes

scientific article published on 28 September 2016

Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer

scientific article published on 27 March 2019

Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines

scientific article published on 01 January 2019

Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin.

scientific article published on 30 January 2012

The cisplatin-based Pt(iv)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions

scientific article published on 01 June 2018

The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells

scientific article published on 9 September 2013